STAGE IIIC BREAST CANCER AJCC V7
Clinical trials for STAGE IIIC BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising breast cancer combo trial halted early
Disease control TerminatedThis study tested a mix of targeted drugs (neratinib, pertuzumab, trastuzumab) plus chemotherapy (paclitaxel) for people with advanced or inflammatory breast cancer. The goal was to find the best dose and see if the combination could eliminate all signs of cancer before surgery. …
Matched conditions: STAGE IIIC BREAST CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:55 UTC
-
New drug cocktail trial targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase trial tested combinations of drugs (bevacizumab, temsirolimus, valproic acid, or cetuximab) in 154 adults with advanced cancers or certain non-cancerous diseases that are progressive and life-limiting. The main goal was to find the safest doses and understand sid…
Matched conditions: STAGE IIIC BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:30 UTC